Navigation Links
Orange County Dentist, Dr. A. Rassouli, Comments on the New Study about Reducing the Risk of Dental Implant Failure
Date:5/3/2017

About three million Americans currently have dental implants, and about a half million more join them every year. The gold standard for replacing teeth, dental implants, are strong, stable, and as close in design to the natural tooth as any currently available restoration can be. However, a 2005 study found that up to ten percent of dental implants can fail, largely due to peri-implantitis. Peri-implantitis is an inflammatory condition that affects the tissues surrounding the implants. It occurs when oral bacteria create biofilms such as plaque, on the implants. Orange County dentist, Dr. A. Rassouli comments on the new study that focuses on reducing the risk of dental implant failure.

Researchers from the University of Plymouth and it’s School of Biological Sciences worked together to develop a nano coating for dental implants specifically designed to prevent peri-implantitis. During the study, which was published in "Nanotoxicology" and described in MedicalXpress.com, the team combined nano coatings that included hydroxyapatite, silver, and titanium oxide and applied them to the surfaces of titanium alloy implants.

The nano coating effectively reduced plaque formation by 97.5 percent and improved the integration process, significantly reducing the risk of infection. More research is needed to demonstrate the safety, effectiveness, and biocompatibility of nano coatings in medical devices for use in humans. However, this study has provided researchers with extensive information about new ways to overcome the risks associated with current infection risk reduction strategies, which include the use of antimicrobial coatings.

Dr. Rassouli offers the latest dental technology, including dental implants. Dental implants can be paired with dental crowns, bridges, or dentures for a fully customized tooth replacement solution. He also offers:

  •     Teeth whitening
  •     Porcelain veneers
  •     Pinhole surgery
  •     Emergency dentistry
  •     Invisalign
  •     One-visit crowns
  •     Dental sedation
  •     TMJ treatments

About Dr. A. Rassouli

Dr. A. Rassouli is a graduate of USC’s Dental School. During his time there, he served on the Accreditation and Ethics Committees and served as the class president for four years in a row. He was also recognized for his academic accomplishments and leadership skills. After graduation, he became a part-time clinical faculty member at the University of Southern California and a member of the prestigious Century Club. He also cofounded the South Coast Dental Academy.

Read the full story at http://www.prweb.com/releases/orangecounty/dentists/prweb14294687.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. The Oncology Institute of Hope and Innovation Further Expands its Presence in the Orange County area with Opening of our Mission Viejo Office
2. Golden Triangle Emergency Center - Orange Celebrates Two-Year Anniversary
3. Orange County Dentist, Dr. A. Rassouli, Comments on the New Vaccine for Periodontitis
4. Brain New Day Talk on Relationship Between Traumatic Brain Injuries and Impaired Driving to Be Given at Orange Ulster Boces
5. Facial Plastic Surgeon Selected as One of the Top Doctors in Orange County!
6. Orange County Dental Office, Center for Oral Health, is Offering Complimentary Consultations for Dental Treatments for a Limited Time
7. The Oncology Institute of Hope and Innovation Further Expands its Presence in the North Orange County Area with Opening of Los Alamitos Office
8. Curd, Galindo & Smith, LLP Announces That Orange County Superior Court Rules TS Cosmetic Labs, Inc. May Sell Its Nail Care Products To Any Customer.
9. Lymphoma Research Foundation to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ
10. Orange County Dentist, Dr. Rassouli, Now Offers Same Day Treatments
11. Orange County Dentist, Dr. Rassouli, Comments on the New Study Now Linking Oral Health and Cognitive Decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... Plano, Texas (PRWEB) , ... May 26, 2017 , ... ... Cord Stimulation System, a powerfully versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita ... , “We are pleased to be the first in Arkansas to introduce the ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: ... FAMILY-Our Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... used to say, he is "panther quick and leather tough." His love for others ...
(Date:5/26/2017)... ... ... Water damage to the flooring of several classrooms at The Fort Lee Elementary ... number of critical issues to address before students could return to classes. , First, ... no disruption to class schedules. Second, the project had to comply with New Jersey ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... , May 15, 2017 Enterin Inc., a privately-held ... and developing novel compounds to treat Parkinson,s disease (PD), has ... is a Phase 1/2a randomized, controlled, multicenter study involving patients ... will enroll 50 patients over a 9-to-12-month period. The first ... 10 patients with PD. Participating sites include Denver ...
Breaking Medicine Technology: